Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages
Experimental Dermatology · 2025-08 · 34 (8)
DOI: 10.1111/exd.70152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, online erschienen am 17.08.2025. Verfasst von Bing Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Psoriasis, Extracellular Vesicles, Mitochondria, Macrophages. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, CSBT Scientific Research Programs Funded by WEGO.
Abstract (Originalsprache)
Platelet‐rich plasma ( PRP ) is a safe, autologous plasma component abundant in cytokines and extracellular vesicles, frequently applied to treat inflammatory disorders. Although PRP demonstrates potential for psoriasis therapy, its underlying mechanism remains insufficiently understood. In this study, various PRP constituents were evaluated in an imiquimod ( IMQ )‐induced mouse model of psoriasis. PRP , platelet‐derived extracellular vesicles ( PEVs ), and platelet‐poor plasma ( PPP ) were isolated from mice and administered subcutaneously. The data showed that PEVs , rather than PPP , served as the principal anti‐psoriatic factor. Furthermore, RNA sequencing and flow cytometry revealed that PEVs markedly suppressed M1 polarisation of macrophages, thereby mitigating psoriatic‐like inflammation. In vitro, PEVs delivered encapsulated mitochondria to RAW264 .7 cells in a concentration‐dependent manner. These functional organelles enhanced oxidative phosphorylation and suppressed glycolysis, driving a metabolic shift favouring an anti‐inflammatory phenotype and attenuating the inflammatory response. In conclusion, PEVs emerge as the primary PRP component responsible for inflammatory suppression in psoriasis. Notably, mitochondria transfer mediated by PEVs underscores a promising therapeutic avenue and provides novel insight into the role of platelet derivatives in inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Institute of Dermatology, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Transfusion Medicine, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
ORCID-Profile: Bing Wang, Dandan Li, Yumeng Wang, Yidong Tan, Yijun Yang, Haifei Liu, Zhirong Yao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- CSBT Scientific Research Programs Funded by WEGO
Zitieren
APA
Wang, B., Li, D., Pan, C., Wang, Y., Tan, Y., Yang, Y., Liu, H., Yao, Z., Zhang, H., & Wang, Z. (2025). Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages. Experimental Dermatology, 34(8). https://doi.org/10.1111/exd.70152
Vancouver
Wang B, Li D, Pan C, Wang Y, Tan Y, Yang Y, et al. Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages. Experimental Dermatology. 2025;34(8). doi:10.1111/exd.70152
BibTeX
@article{Wang2025,
author = {Wang, Bing and Li, Dandan and Pan, Chaolan and Wang, Yumeng and Tan, Yidong and Yang, Yijun and Liu, Haifei and Yao, Zhirong and Zhang, Hui and Wang, Zhicheng},
title = {Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages},
journal = {Experimental Dermatology},
year = {2025},
volume = {34},
number = {8},
doi = {10.1111/exd.70152}
}
EUVIMED